Exicure

-$0.04 (-2.40%) As of 6:00 PM UTC today

Why Robinhood?

You can buy or sell Exicure and other stocks, options, and ETFs commission-free!

About XCUR

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN.

CEO
David A. Giljohann
Employees
63
Headquarters
Chicago, Illinois
Founded
2011

XCUR Key Statistics

Market Cap
148.61M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
284.16K
High Today
$1.65
Low Today
$1.62
Open Price
$1.65
Volume
163.95K
52 Week High
$3.14
52 Week Low
$1.38

XCUR Earnings

-$0.14
-$0.09
-$0.04
$0.01
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure